Investorideas.com Newswire

Investorideas.com Newswire
Be one of the most talked about companies (stocks) on social media

Investorideas.com newswire, biotech stocks and industry

Tuesday, September 21, 2010

Investorideas.com - Actively Trading Biotech and Pharmaceutical Stocks: OTCVolumeleaders.com Reports on OTCBB Market ($2.00-$5.00): (OTCBB: KMKCF), (OTCBB: BOPH), (OTCBB: ENHD), (OTCBB: AVXL)

Investorideas.com - Actively Trading Biotech and Pharmaceutical Stocks: OTCVolumeleaders.com Reports on OTCBB Market ($2.00-$5.00): (OTCBB: KMKCF), (OTCBB: BOPH), (OTCBB: ENHD), (OTCBB: AVXL)

Sign up at OTC Volume leaders and get access to info on hundreds of the most active OTCBB companies by clicking the sign up link belowhttp://bit.ly/otcvolumeleadersNote to Editors: The Following Is an Investment Opinion Being Issued by OTC VOLUME LEADERSCategory: Investment, FinancialSubscribe to Investor Ideas Newswire
Visit this company: www.otcvolumeleaders.com

Point Roberts, WA (Investorideas.com Newswire) September 21, 2010 - OTC VOLUME LEADERS reports on the most active trading stocks on the OTCBB. OTC Volume leaders ($2.00-$5.00) include CONTINENTAL MINERALS (OTCBB: KMKCF), Bohai Pharmaceuticals Group, Inc. (OTCBB: BOPH), Energroup Holdings Corp. (OTCBB: ENHD), Anavex Life Sciences Corp. (OTCBB: AVXL).

Sign up for Tomorrows Hot OTC Market Leaders Today! http://bit.ly/otcvolumeleadersOTC/Market Commentary:One of the OTCBB volume leader reports; Recent News: "Bohai Pharmaceuticals Group, a TCM pharmaceutical company, said it has added five marketed products to its portfolio so far this year, bringing its total to ten. Bohai holds the rights to produce another 14 TCM formulations in China.Three of the newly introduced products are prescription drugs, while the remaining two are OTC medicines. The new products will complement Bohai's flagship offerings, Tongbi Capsules and Tablets and Lung Nourishing Cream, which were added to the National Drug Reimbursement list in late 2009."Full Article: http://seekingalpha.com/article/225881-bohai-pharma-doubles-portfolio-products?source=yahooMarket Snapshot: (at time of release)Dow 10,734.55 -19.07 -0.18%
Nasdaq 2,345.72 -10.11 -0.43%
S&P 500 1,137.60 -5.11 -0.45%
10 Yr Bond(%) 2.6650% -0.4100
Oil 73.01 -1.69 -2.26%
Gold 1,275.80 -3.20 -0.25%


OTCBB Investors: Take the few minutes to register with us at To sign up for free Newsletter http://bit.ly/otcvolumeleaders and get access to info on hundreds of the most active OTCBB companies and keep up to date with developments of the companies.OTC VOLUME LEADERS provides investors with daily market updates showcasing the most actively traded OTCBB Companies. We strive to provide you with the most up-to-date market information and activity by searching through hundreds of OTCBB companies in order to provide you information on the best of these companies. The goal is to continually find tomorrow’s market leading companies, today!OTCVolumeleaders.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.Please view the full disclaimer: http://www.otcvolumeleaders.com/Source http://www.otcvolumeleaders.com/


Follow OTC Volume Leaders on Twitter.com http://twitter.com/OTCVolumeLeader

* Attention Investors in British Columbia Canada: Do not subscribe to any OTC stocks not currently filing with Sedar in BC and BC SecuritiesVisit the OTC showcase profile at Investorideas.com Request News and Info on OTC Disclosure, Disclaimer/ OTC is a paid advertising client on Investorideas.com.More Info:Published at www.Investorideas.com - Global research by sectorsIf you have any questions regarding information in this press release please contact the company listed in the press release.Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

No comments:

Post a Comment